← Leaderboards
Arthur Trenton De La Cruz-Lynch
University Of Minnesota
$114,718
Attributed
$114,718
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.3K · FY2023–25$50K$37.5K$25K$12.5K$0
'23
'24
'25
Funding mix
By agency
NIH$114,718 · 1
By mechanism
F30$114,718 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Louise Christine Evans$1,932,917
- Ida Tchuisseu Fonkoue$742,088
- Christopher T Banek$2,126,629
- Christine Schwartz$150,745
- Brianna Dailey-Krempel$75,642
Others in their field
Other Rising Stars on “Clinically Significant”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Mari Ostendorf · University Of Washington$51,931,230
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Suma Babu · Massachusetts General Hospital$11,004,714
Research focus
Clinically SignificantClinical TrialsAcetatesAnatomyAfferent NerveAblationApplications GrantsAftercareBiological MarkersBlood PressureBlood Pressure ReductionBlood Pressure RegulationBlood VolumeBrainCapsaicinCardiac OutputCardiovascular DiseasesCardiovascular Risk FactorCathetersCellsChemokineChronicClinically RelevantComparative Efficacy
Grant awards (3)
Evaluating the Mechanisms of Afferent Renal Nerve Ablation as a Treatment for Hypertension$25,518
F30 · FY2025 · HL · contact PI
Evaluating the Mechanisms of Afferent Renal Nerve Ablation as a Treatment for Hypertension$49,324
F30 · FY2024 · HL · contact PI
Evaluating the Mechanisms of Afferent Renal Nerve Ablation as a Treatment for Hypertension$39,876
F30 · FY2023 · HL · contact PI